ALK-Abello A/S (AKBLF)
35.80
0.00 (0.00%)
USD |
OTCM |
Feb 26, 16:00
ALK-Abello EPS Diluted (Quarterly) : 0.1871 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Genmab A/S | 0.0461 |
| Ascendis Pharma A/S | -0.6364 |
| Zealand Pharma A/S | -0.8368 |
| Bavarian Nordic A/S | 0.7287 |
| Evaxion AS | -0.2862 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 41.46M |
| Revenue (Quarterly) | 270.08M |
| Total Expenses (Quarterly) | 228.63M |
| Enterprise Value | 7.803B |
| Gross Profit Margin (Quarterly) | 68.09% |
| Profit Margin (Quarterly) | 15.35% |
| Earnings Yield | 2.28% |
| Operating Earnings Yield | 3.15% |
| Normalized Earnings Yield | 2.276 |